Volume 116, Issue 6, Pages (March 2004)

Slides:



Advertisements
Similar presentations
Structure of the Rho Family GTP-Binding Protein Cdc42 in Complex with the Multifunctional Regulator RhoGDI  Gregory R. Hoffman, Nicolas Nassar, Richard.
Advertisements

Crystal Structure of Glycogen Synthase Kinase 3β
Volume 10, Issue 7, Pages (July 2002)
Volume 11, Issue 3, Pages (March 2007)
Oncogenic B-Raf mutations
Jue Chen, Gang Lu, Jeffrey Lin, Amy L Davidson, Florante A Quiocho 
Volume 15, Issue 5, Pages (September 2004)
Volume 11, Issue 10, Pages (October 2004)
Volume 7, Issue 3, Pages (March 2001)
Volume 14, Issue 3, Pages (March 2001)
by Alexey Dementiev, Abel Silva, Calvin Yee, Zhe Li, Michael T
Volume 15, Issue 8, Pages (August 2007)
Volume 12, Issue 2, Pages (August 2003)
Volume 14, Issue 3, Pages (March 2006)
Volume 21, Issue 6, Pages (March 2006)
Volume 85, Issue 7, Pages (June 1996)
Intramolecular interactions of the regulatory domains of the Bcr–Abl kinase reveal a novel control mechanism  Hyun-Joo Nam, Wayne G Haser, Thomas M Roberts,
Volume 36, Issue 4, Pages (November 2009)
Structural Basis for an Unexpected Mode of SERM-Mediated ER Antagonism
Ubiquitin Recognition by the Human TSG101 Protein
Volume 14, Issue 5, Pages (May 2006)
Volume 119, Issue 3, Pages (October 2004)
Substrate Recognition Mechanism of Atypical Protein Kinase Cs Revealed by the Structure of PKCι in Complex with a Substrate Peptide from Par-3  Chihao.
Crystal Structures of Ral-GppNHp and Ral-GDP Reveal Two Binding Sites that Are Also Present in Ras and Rap  Nathan I. Nicely, Justin Kosak, Vesna de Serrano,
Crystal Structure of an Inactive Akt2 Kinase Domain
Volume 13, Issue 4, Pages (April 2005)
Crystal Structure of PMM/PGM
Volume 9, Issue 6, Pages (June 2002)
Recognition of a TG Mismatch
Moosa Mohammadi, Joseph Schlessinger, Stevan R Hubbard  Cell 
Volume 90, Issue 1, Pages (July 1997)
Crystal Structure of the TAO2 Kinase Domain
Zhenjian Cai, Nabil H. Chehab, Nikola P. Pavletich  Molecular Cell 
Daniel Peisach, Patricia Gee, Claudia Kent, Zhaohui Xu  Structure 
Volume 95, Issue 7, Pages (December 1998)
Crystal Structure of Glycogen Synthase Kinase 3β
Volume 23, Issue 4, Pages (April 2015)
Volume 3, Issue 5, Pages (May 1999)
Volume 3, Issue 5, Pages (May 1999)
Volume 116, Issue 6, Pages (March 2004)
Structure and Regulation of the CDK5-p25nck5a Complex
Jonathan Goldberg, Angus C Nairn, John Kuriyan  Cell 
Volume 21, Issue 3, Pages (March 2013)
Crystal Structure of a Phosphoinositide Phosphatase, MTMR2
Volume 12, Issue 6, Pages (June 2004)
Activation Mechanism of the MAP Kinase ERK2 by Dual Phosphorylation
Tianjun Zhou, Liguang Sun, John Humphreys, Elizabeth J. Goldsmith 
Structure of the Rho Family GTP-Binding Protein Cdc42 in Complex with the Multifunctional Regulator RhoGDI  Gregory R. Hoffman, Nicolas Nassar, Richard.
Solution Structure of a TBP–TAFII230 Complex
E.Radzio Andzelm, J Lew, S Taylor  Structure 
Active and Inactive Protein Kinases: Structural Basis for Regulation
Structure of the Staphylococcus aureus AgrA LytTR Domain Bound to DNA Reveals a Beta Fold with an Unusual Mode of Binding  David J. Sidote, Christopher.
Active and Inactive Protein Kinases: Structural Basis for Regulation
Hideki Kusunoki, Ruby I MacDonald, Alfonso Mondragón  Structure 
Jue Wang, Jia-Wei Wu, Zhi-Xin Wang  Structure 
Arvin C. Dar, Michael S. Lopez, Kevan M. Shokat  Chemistry & Biology 
Volume 87, Issue 7, Pages (December 1996)
Crystal Structure of the Tyrosine Phosphatase SHP-2
Volume 11, Issue 1, Pages (January 2003)
Thomas A Graham, Wilson K Clements, David Kimelman, Wenqing Xu 
Volume 18, Issue 3, Pages (April 2005)
Guilty as charged Cancer Cell
Three protein kinase structures define a common motif
Structural Insights into RIP3-Mediated Necroptotic Signaling
The Structure of the GGA1-GAT Domain Reveals the Molecular Basis for ARF Binding and Membrane Association of GGAs  Brett M. Collins, Peter J. Watson,
The Structure of Sortase B, a Cysteine Transpeptidase that Tethers Surface Protein to the Staphylococcus aureus Cell Wall  Yinong Zong, Sarkis K Mazmanian,
Volume 6, Issue 3, Pages (February 2014)
Structural Basis for Activation of ARF GTPase
Volume 21, Issue 6, Pages (June 2013)
Volume 4, Issue 4, Pages (October 1999)
Presentation transcript:

Volume 116, Issue 6, Pages 855-867 (March 2004) Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF  Paul T.C Wan, Mathew J Garnett, S.Mark Roe, Sharlene Lee, Dan Niculescu-Duvaz, Valerie M Good, Cancer Genome Project, C.Michael Jones, Christopher J Marshall, Caroline J Springer, David Barford, Richard Marais  Cell  Volume 116, Issue 6, Pages 855-867 (March 2004) DOI: 10.1016/S0092-8674(04)00215-6

Figure 1 Characterization of Activated Mutant B-RAF Proteins from Human Cancer The indicated myc-epitope-tagged wild-type and mutant B-RAF proteins were expressed in COS cells and their kinase activity was measured. Where indicated, G12VRAS (RAS) was included in the transfections. (A) B-RAF kinase activity for high activity mutants. (B) B-RAF kinase activity for intermediate activity mutants. (C) Western blot of myc-tagged B-RAF, total ERK2, and ppERK in COS cells expressing the high and intermediate activity mutants. (D) ERK kinase activity in COS cells expressing B-RAF mutant proteins. Cell 2004 116, 855-867DOI: (10.1016/S0092-8674(04)00215-6)

Figure 2 Characterization of Impaired Activity B-RAF Mutants (A) B-RAF kinase activity. (B) ppERK staining in COS cells extracts. (C) ERK kinase activity in COS cell extracts. (D) MEK phosphorylation in COS cells expressing B-RAF mutants or G12VRAS. (E) ERK activation in Xenopus embryos expressing the indicated B-RAF mutants or uninjected control. Cell 2004 116, 855-867DOI: (10.1016/S0092-8674(04)00215-6)

Figure 3 C-RAF Is Required for ERK Activation by the Impaired B-RAF Mutants (A) B-RAF and C-RAF complex analysis in COS cells. Levels of exogenous B-RAF and endogenous C-RAF are shown in the lower two panels and B-RAF in the C-RAF IP in the upper panel. Identical results were obtained using two different anti-C-RAF antibodies. (B) Kinase activity of endogenous C-RAF from COS cells expressing the indicated B-RAF mutant. (C) The RAF activity in C-RAF immunoprecipitates from COS cells expressing WTC-RAF (WT) or KDC-RAF (KD) together with the indicated B-RAF constructs. (D) C-RAF depletion in COS cells. COS cells expressing the B-RAF mutant indicated were treated with C-RAF or scrambled control (SCR) siRNA oligonucleotides as indicated and the levels of mutant B-RAF, endogenous C-RAF, phosphorylated ERK, and total ERK are shown. (E) Endogenous ERK kinase activity in COS cells expressing B-RAF mutants and treated with siRNA. (F) C-RAF depletion in cancer cell lines. WM266-4 and H1666 cells were treated under mock conditions or with the C-RAF, B-RAF, and scrambled control (SCR) siRNA oligonucleotides as indicated, and the levels of endogenous B-RAF, C-RAF, phosphorylated ERK, and total ERK are shown. Cell 2004 116, 855-867DOI: (10.1016/S0092-8674(04)00215-6)

Figure 4 Structure of WTΔB-RAF Kinase Domain (A) Ribbons diagram of WTΔB-RAF kinase domain in complex with BAY43-9006. The positions of Asp593 and Phe594 of the DFG motif, Asn580 of the catalytic loop, and Glu585 are shown, DFG and APE motif in yellow, rest of activation segment and the N region are in red. N lobe is in magenta, C lobe in marine, and P loop in orange. Residues 600–611 of the activation loop are disordered (dashed lines). (B) Schematic of B-RAF primary structure, showing functional domains and position of 32 observed cancer-associated mutants of B-RAF. The amino acid substitutions are color coded according to their activity class. Figures were made with PyMOL (http://www.pymol.org). Cell 2004 116, 855-867DOI: (10.1016/S0092-8674(04)00215-6)

Figure 5 Interactions between BAY43-9006 and ΔB-RAF and Comparison with c-Abl Inhibitor Complexes (A) Stereoview of BAY43-9006 bound to the interdomain cleft of ΔB-RAF. The 2Fo-Fc electron density omit map was calculated from phases derived from a simulated annealing refinement of the structure omitting the inhibitor. The map is contoured at 1σ. For clarity, the activation segment is not shown. (B) c-Abl-STI-571 and (C) c-Abl-PD173855. The color scheme for ΔB-RAF is the same as Figure 4, c-Abl is cyan. The side chain of the DFG motif Phe residue is shown for both kinases. In the STI-571 complex, the DFG motif overlaps that of ΔB-RAF. Cell 2004 116, 855-867DOI: (10.1016/S0092-8674(04)00215-6)

Figure 6 Position of Oncogenic Mutants of B-RAF and Mechanism of Activation by Thr598 Phosphorylation (A) The molecular surface generated by the P loop (residues 463–468) and the DFG motif/activation segment (residues 593–599) are colored green and yellow, respectively, demonstrating the hydrophobic cluster created by the association of the P loop with the DFG motif, a conformation stabilized by the hydrogen bond between the amide side chain of Asn580 and the main chain amide of Phe594. (B) A ribbon representation of the structure of the activation segment of PKB is superimposed onto ΔB-RAF, together with the side chains of Asp293 (Asp593), Lys298 (Thr598), Glu299 (Val599), Ile301 (Ser601), phosphoThr309, and the catalytic Asp275 (Asp575) and Arg274 (B-RAF residues in parenthesis). In B-RAF, Glu599 and Glu600 (equivalent to Glu299 and Glu300 of PKB) could contact Lys569 of the αE helix. Any substitution at Val599 will be tolerated. The position of Glu600 is modeled from Gly300 of PKB. Structure of the activation segment is taken from PKB (Yang et al., 2002). Phosphorylation of Thr598 of B-RAF would position a phosphate group in the equivalent position as the phosphate of Thr309 of PKB, allowing interaction with Arg575 of the B-RAF catalytic loop RD motif. The equivalent of B-RAF Val599 is a Glu in PKB, suggesting that in the V599EB-RAF mutant, Glu599 will be solvent exposed and likely to interact with Lys506 of the αC helix. Cell 2004 116, 855-867DOI: (10.1016/S0092-8674(04)00215-6)

Figure 7 Activating and Impaired Activity B-RAF Mutants Stimulate ERK Signaling through Distinct Mechanisms (A) The activated mutants can directly phosphorylate and activate MEK and although they also activate C-RAF, their ability to signal to ERK does not require this pathway. (B) The impaired activity B-RAF mutants cannot stimulate efficient activation of MEK, but can stimulate C-RAF activity, which then activates MEK. Their ability to signal to ERK is therefore dependent on C-RAF protein. Cell 2004 116, 855-867DOI: (10.1016/S0092-8674(04)00215-6)